User login




Popular diabetes drug puts heart at risk

|

Two studies released on Monday reported serious heart risks with GlaxoSmithKline Plc diabetes pill Avandia as U.S. regulators decide whether the drug should stay on the market. GlaxoSmithKline - Diabetes mellitus - Health - United States - Diabetes